|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,601.00 GBX | +0.07% |
|
-1.75% | +29.86% |
| 06:16am | Hutchmed drugs stay on NRDL; Tazverik added to new insurance list | AN |
| 04:40am | JPMorgan cuts M&G, UBS cuts Trainline | AN |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 281B | A | |||||||
| 905B | A | |||||||
| 487B | BBB | |||||||
| 400B | AA | |||||||
| 330B | AA | |||||||
| 255B | AAA | |||||||
| 248B | A | |||||||
| 214B | A | |||||||
| 178B | A | |||||||
| 150B | AAA | |||||||
| 148B | BBB | |||||||
| 120B | A | |||||||
| 116B | AA | |||||||
| 106B | A | |||||||
| 96.56B | AA | |||||||
| 87.18B | AA | |||||||
| 63.66B | - | - | - | - | - | - | - | |
| 60.52B | AA | - | ||||||
| 57.93B | AA | |||||||
| 44.82B | AA | |||||||
| Average | 217.38B | AA | |||||||
| Weighted average by Cap. | AA |
- Stock Market
- Equities
- AZN Stock
- Sector AstraZeneca PLC
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
